AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2007
Nov 14, 2007
34117_dirs_2007-11-14_bba6b711-0a97-40b1-8081-25bbd0531328.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-11-12
Reporting Person: DISANTO FRANK J (Director, President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-11-12 | Employee Stock Option | $1.17 | A | 300000 | Acquired | 2017-11-11 | Common Stock (300000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6